StockData
Moleculin Biotech, Inc. logo

Moleculin Biotech, Inc. (MBRX) shareholders

MBRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$6.83−0.31 (-4.34%)

Close on Nov 17, 2026Market cap $133.03MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
0.0%
0M of 19M shares
Institutional holders
18
5 new, 7 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
3 buys · 0 sales
Net bought $0

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Klemp Walter V2,070,7619.90%13D (active)Aug 19, 2026
CVI Investments, Inc.
Joint filing with Heights Capital Management, Inc. (9.90%)
1,863,3779.90%13G (passive)Jul 31, 2026
Foster Jonathan P.1,288,2076.30%13D (active)Aug 19, 2026
Steven Boyd
Joint filing with Armistice Capital, LLC (9.99%)
339,7679.99%13G (passive) amendmentDec 31, 2024

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of MBRXValueChange% of portfolio
Geode Capital Management, LLC2,3630.01%$131.83K+7460.00%
Vanguard Capital Management LLC2,1110.01%$117.78K+1,4180.00%
Vanguard Fiduciary Trust Co1,4940.01%$83.37K+1,1900.00%
XTX Topco Ltd1,1470.01%$64.01KNew0.00%
Morgan Stanley1,0020.01%$55.90K+1,0000.00%
Rockefeller Capital Management L.P.7500.00%$41.85K+5290.00%
Tower Research Capital LLC (TRC)1750.00%$9.80K+830.00%
Citigroup Inc1340.00%$7.46KNew0.00%
Barclays PLC310.00%$1.73KNew0.00%
BlackRock, Inc.250.00%$1.37K–0.00%
EFG International AG220.00%$1.21K–0.00%
Jones Financial Companies Lllp180.00%$1.18KNew0.00%
Wells Fargo & Company/Mn100.00%$558New0.00%
Newbridge Financial Services Group, Inc.60.00%$318–0.00%
SBI Securities Co., Ltd.20.00%$123–0.00%
Danske Bank A/S00.00%$6–0.00%
Osaic Holdings, Inc.00.00%$2–0.00%
CVA Family Office, LLC00.00%$3–0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026180M0.0%5 / 60 / 70M0M
Q1 2026200M0.0%7 / 41 / 30M0M
Q4 2025170M0.0%17 / 00 / 00M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

5 funds held MBRX in Q2 2026, 48% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of MBRXValue% of fundAs of
Vanguard Extended Market Index Fund28,2740.15%$78.88K0.00%Jun 30, 2026
Fidelity Extended Market Index Fund21,9010.11%$61.10K0.00%May 31, 2026
Fidelity Nasdaq Composite Index Fund4,4840.02%$12.51K0.00%May 31, 2026
Fidelity Series Total Market Index Fund3,1420.02%$8.77K0.00%May 31, 2026
Fidelity Total Market Index Fund9150.00%$2.55K0.00%May 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Walter V. KlempCEO and President, Director1,111,2035.71%Nov 6, 2026
Jonathan P. FosterChief Financial Officer20,2910.10%Nov 6, 2026
Donald H. PickerChief Science Officer560,7182.88%Nov 6, 2026
John M. ClimacoDirector––Nov 14, 2025
Michael D. CannonDirector––Nov 14, 2025
Robert E. GeorgeDirector14,6600.08%Nov 14, 2025
Elizabeth CermakDirector––Nov 14, 2025
Joy YanDirector––Nov 14, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Donald H. Picker
Chief Science Officer
Nov 4, 2026Tax withholding−4$8.46$348,718
Donald H. Picker
Chief Science Officer
Nov 4, 2026Option exercise+17––8,722
Jonathan P. Foster
Chief Financial Officer
Nov 4, 2026Tax withholding−10$8.46$8520,291
Jonathan P. Foster
Chief Financial Officer
Nov 4, 2026Option exercise+41––20,301
Walter V. Klemp
CEO and President, Director
Nov 4, 2026Tax withholding−14$8.46$11836,203
Walter V. Klemp
CEO and President, Director
Nov 4, 2026Option exercise+57––36,217
Walter V. Klemp
CEO and President, Director
Oct 15, 2026Tax withholding−48,659$0.37$18.01K723,181
Walter V. Klemp
CEO and President, Director
Oct 15, 2026Option exercise+207,500––771,840
Jonathan P. Foster
Chief Financial Officer
Oct 15, 2026Tax withholding−30,485$0.37$11.28K405,188
Jonathan P. Foster
Chief Financial Officer
Oct 15, 2026Option exercise+130,000––435,673
Donald H. Picker
Chief Science Officer
Aug 3, 2026Buy+173,333––174,086
Jonathan P. Foster
Chief Financial Officer
Aug 3, 2026Buy+293,333––305,673
Walter V. Klemp
CEO and President, Director
Aug 3, 2026Buy+533,333––564,340
Jonathan P. Foster
Chief Financial Officer
Jun 22, 2026Tax withholding−41$3.12$12812,340
Jonathan P. Foster
Chief Financial Officer
Jun 22, 2026Option exercise+174––12,381
Walter V. Klemp
CEO and President, Director
Jun 22, 2026Tax withholding−88$3.12$27531,007
Walter V. Klemp
CEO and President, Director
Jun 22, 2026Option exercise+360––31,088
Donald H. Picker
Chief Science Officer
Jun 22, 2026Option exercise+71––774
Donald H. Picker
Chief Science Officer
Jun 22, 2026Tax withholding−21$3.12$66753
Jonathan P. Foster
Chief Financial Officer
Jun 20, 2026Tax withholding−31$2.88$8912,207
Jonathan P. Foster
Chief Financial Officer
Jun 20, 2026Option exercise+109––12,238
Walter V. Klemp
CEO and President, Director
Jun 20, 2026Option exercise+150––30,765
Walter V. Klemp
CEO and President, Director
Jun 20, 2026Tax withholding−37$2.88$10730,728
Donald H. Picker
Chief Science Officer
Jun 20, 2026Tax withholding−13$2.88$37703
Donald H. Picker
Chief Science Officer
Jun 20, 2026Option exercise+44––716
Jonathan P. Foster
Chief Financial Officer
Nov 4, 2025Option exercise−5,023$0.50$2.51K303,189
Jonathan P. Foster
Chief Financial Officer
Nov 4, 2025Option exercise+20,625––308,212
Donald H. Picker
Chief Science Officer
Nov 4, 2025Option exercise+8,750––18,902
Donald H. Picker
Chief Science Officer
Nov 4, 2025Tax withholding−2,131$0.50$1.07K16,771
Walter V. Klemp
CEO and President, Director
Nov 4, 2025Tax withholding−7,001$0.50$3.50K765,356
Walter V. Klemp
CEO and President, Director
Nov 4, 2025Option exercise+28,750––772,357
Walter V. Klemp
CEO and President, Director
Jun 23, 2025Buy+675,675$0.37$250.00K743,607
Jonathan P. Foster
Chief Financial Officer
Jun 23, 2025Buy+270,270$0.37$100.00K287,587
Walter V. Klemp
CEO and President, Director
Jun 22, 2025Option exercise+8,990––70,122
Walter V. Klemp
CEO and President, Director
Jun 22, 2025Tax withholding−2,190$0.27$59167,932
Jonathan P. Foster
Chief Financial Officer
Jun 22, 2025Option exercise+4,328––18,371
Jonathan P. Foster
Chief Financial Officer
Jun 22, 2025Tax withholding−1,054$0.27$28517,317
Donald H. Picker
Chief Science Officer
Jun 22, 2025Option exercise+1,766––10,582
Donald H. Picker
Chief Science Officer
Jun 22, 2025Tax withholding−430$0.27$11610,152
Walter V. Klemp
CEO and President, Director
Jun 20, 2025Tax withholding−914$0.27$24761,132
Walter V. Klemp
CEO and President, Director
Jun 20, 2025Option exercise+3,750––62,046
Jonathan P. Foster
Chief Financial Officer
Jun 20, 2025Tax withholding−661$0.27$17814,043
Jonathan P. Foster
Chief Financial Officer
Jun 20, 2025Option exercise+2,711––14,704
Donald H. Picker
Chief Science Officer
Jun 20, 2025Tax withholding−263$0.27$718,816
Donald H. Picker
Chief Science Officer
Jun 20, 2025Option exercise+1,078––9,079
Walter V. Klemp
CEO and President, Director
Jun 16, 2025Tax withholding−406$0.69$28058,296
Walter V. Klemp
CEO and President, Director
Jun 16, 2025Option exercise+1,667––58,702
Jonathan P. Foster
Chief Financial Officer
Jun 16, 2025Option exercise+833––12,196
Jonathan P. Foster
Chief Financial Officer
Jun 16, 2025Tax withholding−203$0.69$14011,993
Walter V. Klemp
CEO and President, Director
Jul 2, 2024Option exercise+982––57,275
Walter V. Klemp
CEO and President, Director
Jul 2, 2024Tax withholding−240$3.57$85757,035
Walter V. Klemp
CEO and President, Director
Jun 22, 2024Option exercise+8,990––58,483
Walter V. Klemp
CEO and President, Director
Jun 22, 2024Tax withholding−2,190$3.74$8.19K56,293
Jonathan P. Foster
Chief Financial Officer
Jun 22, 2024Option exercise+4,329––12,416
Jonathan P. Foster
Chief Financial Officer
Jun 22, 2024Tax withholding−1,053$3.74$3.94K11,363
Donald H. Picker
Chief Science Officer
Jun 22, 2024Tax withholding+524$3.74$1.96K8,001
Donald H. Picker
Chief Science Officer
Jun 22, 2024Option exercise+1,766––8,525
Walter V. Klemp
CEO and President, Director
Jun 20, 2024Tax withholding−914$3.78$3.45K49,493
Walter V. Klemp
CEO and President, Director
Jun 20, 2024Option exercise+3,750––50,407
Donald H. Picker
Chief Science Officer
Jun 20, 2024Tax withholding−320$3.78$1.21K6,759

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
0.35%
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
-56.8%
From 0M shares
Short volume, 20 days
57.5%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Moleculin Biotech's stock actually held short. Settlement fails (shares not delivered on time) peaked at 49,019 shares on Sep 23, 2026 over the last 90 days.

See a number that looks wrong?